
Coca-Cola Company (The) (KO)
NYSEConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-07-07
Reading KO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KO free→
NYSEConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-07-07
Reading KO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KO free→QuarterlyIQ Insights · KO
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $84.00. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $84 the market pays 27× p/e — above the 19× p/e peer median but in line with its own 25× history. That premium reflects a durable franchise our peer-anchored $63 fair value understates; treat the 'expensive vs peers' read with low confidence. Analysts target $84–$89. Note: our $63 fair value sits below the entire analyst range ($84–$89). Even the durable-growth case — current growth held at sustainable margins — values it at about $78, at or below today's price, so you're paying beyond even the growth case. Not investment advice.
$84.00 – $89.00 (median $88.00) · 6 analysts · as of 2026-06-26
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 79% over what the business is worth with no growth; closing that gap needs roughly — years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $2.51/sh owner earnings.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $88.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $74.14 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $73.22 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $26.20 | — | — | TTM | high |
| graham number | 12M | $24.15 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $60.36 | 16.9 | 4.02 | TTM | high |
| Peer P/FCF | 12M | $59.23 | 20.3 | 2.91 | TTM | high |
| Peer P/E | 12M | $60.26 | 19.3 | 3.13 | TTM | high |
| Peer P/S | 12M | $19.43 | 1.7 | 11.42 | TTM | high |
| PEG | 12M | $76.87 | 24.6 | 3.13 | TTM | high |
| residual income | 12M | $17.74 | — | — | TTM | high |
| Own P/E history | 12M | $79.25 | 25.3 | 3.13 | TTM | high |
| triangulated | 12M | $63.30 | 19.3 | 3.29 | Triangulated | high |
| Peer P/FCF | 3Y | $82.56 | 20.3 | 4.06 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $68.17 | 19.3 | 3.54 | Analyst | medium |
| Peer P/S | 3Y | $20.05 | 1.7 | 11.79 | Analyst | medium |
| PEG | 3Y | $86.96 | 24.6 | 3.54 | Analyst | medium |
| Own P/E history | 3Y | $89.65 | 25.3 | 3.54 | Analyst | medium |
| Peer P/FCF | 5Y | $103.02 | 20.3 | 5.06 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $69.58 | 19.3 | 3.61 | Analyst | high |
| Peer P/S | 5Y | $20.47 | 1.7 | 12.04 | Analyst | high |
| PEG | 5Y | $88.77 | 24.6 | 3.61 | Analyst | high |
| Own P/E history | 5Y | $91.51 | 25.3 | 3.61 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.